Making the diagnosis of asthma

Respiratory Care

Volumn 53, Issue 5, 2008, Pages 583-590

  McCormack, Meredith C ^a   Enright, Paul L ^b  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

Author keywords

Asthma; Bronchodilator; Diagnosis; Methacholine; Pulmonary function; Spirometry

Indexed keywords

BRONCHODILATING AGENT; CARBON MONOXIDE; METHACHOLINE; NITRIC OXIDE;

AIRWAY OBSTRUCTION; ALLERGIC ASTHMA; ALLERGY TEST; ASTHMA; BRONCHODILATOR RESPONSE TESTING; CONFERENCE PAPER; DIAGNOSTIC IMAGING; DIFFERENTIAL DIAGNOSIS; DISEASE SEVERITY; HUMAN; INHALATION TEST; LUNG CAPACITY; RADIOALLERGOSORBENT TEST; RESPIRATORY THERAPIST; SKIN TEST; SPIROMETRY; SYMPTOM; THORAX RADIOGRAPHY; CHRONIC OBSTRUCTIVE LUNG DISEASE; COMORBIDITY; PATHOPHYSIOLOGY; REVIEW; SMOKING;

ASTHMA; BRONCHIAL PROVOCATION TESTS; COMORBIDITY; DIAGNOSIS, DIFFERENTIAL; HUMANS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RADIOALLERGOSORBENT TEST; SKIN TESTS; SMOKING; SPIROMETRY;

EID: 50049122255     PISSN: 00201324     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (63)

1. Pearce N, Pekkanen J, Beasley R. How much asthma is really attributable to atopy? Thorax 1999;54(3):268-272.
2. Dicpinigaitis PV. Chronic cough due to asthma: ACCP evidence-based clinical practice guidelines. Chest 2006;129(1 Suppl):75S-79S. (Pubitemid 43265208)
3. Irwin RS. Assessing cough severity and efficacy of therapy in clinical research: ACCP evidence-based clinical practice guidelines. Chest 2006;129(1 Suppl):232S-237S. (Pubitemid 43265227)
4. Expert panel report 3: guidelines for the diagnosis and management of asthma. Bethesda MD: National Institutes of Health, National Asthma Education and Prevention Program; 2007. NIH Publication No. 08-4051. Available from http://www.nhlbi.nih.gov/guidelines/ asthma/asthgdln.pdf. Accessed February 29, 2008.
5. Nair SJ, Daigle KL, DeCuir P, Lapin CD, Schramm CM. The influence of pulmonary function testing on the management of asthma in children. J Pediatr 2005;147(6):797-801. (Pubitemid 41774836)
6. Russell NJ, Crichton NJ, Emerson PA, Morgan AD. Quantitative assessment of the value of spirometry. Thorax 1986;41(5):360-363. (Pubitemid 16114961)
7. Pellegrino R, Viegi G, Brusasco V, Crapo RO, Burgos F, Casaburi R, et al. Interpretative strategies for lung function tests. Eur Respir J 2005;26(5):948-968. (Pubitemid 41632054)
8. Hnizdo E, Glindmeyer HW, Petsonk EL, Enright P, Buist AS. Case definitions for chronic obstructive pulmonary disease. COPD 2006; 3(2):95-100. (Pubitemid 43739181)
9. Ibrahim WH, Gheriani HA, Almohamed AA, Raza T. Paradoxical vocal cord motion disorder: past, present and future. Postgrad Med J 2007;83(977):164-172. (Pubitemid 46465519)
10. King CS, Moores LK. Clinical asthma syndromes and important asthma mimics. Respir Care 2008;53(5):568-580; discussion 580-582.
11. Yawn BP, Enright PL, Lemanske RF Jr, Israel E, Pace W, Wollan P, et al. Spirometry can be done in family physicians' offices and alters clinical decisions in management of asthma and COPD. Chest 2007; 132(4):1162-1168. (Pubitemid 47620988)
12. Silverman RA, Flaster E, Enright PL, Simonson SG. FEV1 performance among patients with acute asthma: results from a multicenter clinical trial. Chest 2007;131(1):164-171. (Pubitemid 46122989)
13. Dykstra BJ, Scanlon PD, Kester MM, Beck KC, Enright PL. Lung volumes in 4,774 patients with obstructive lung disease. Chest 1999; 115(1):68-74. (Pubitemid 29047055)
14. Hankinson JL, Filios MS, Kinsley KB, Petsonk EL. Comparing Mini- Wright and spirometer measurements of peak expiratory flow. Chest 1995;108(2):407-410.
15. Miller MR, Atkins PR, Pedersen OF. Inadequate peak expiratory flow meter characteristics detected by a computerised explosive decompression device. Thorax 2003;58(5):411-416. (Pubitemid 36560944)
16. Fonseca JA, Costa-Pereira A, Delgado L, Silva LN, Magalhaes M, Castel-Branco MG, et al. Pulmonary function electronic monitoring devices: a randomized agreement study. Chest 2005;128(3):1258-1265. (Pubitemid 41324405)
17. 1] Arch Bronconeumol 2006;42(3):144-147. Article in Spanish.
18. Brand PL, Quanjer PH, Postma DS, Kerstjens HA, Koeter GH, Dekhuijzen PN, et al. Interpretation of bronchodilator response in patients with obstructive airways disease. The Dutch Chronic Non- Specific Lung Disease (CNSLD) Study Group. Thorax 1992;47(6): 429-436.
19. Quanjer PH. Predicted values: how should we use them? Thorax 1988;43(8):663-664.
20. Calverley PM, Burge PS, Spencer S, Anderson JA, Jones PW. Bronchodilator reversibility testing in chronic obstructive pulmonary disease. Thorax 2003;58(8):659-664. (Pubitemid 36976273)
21. Celli BR, MacNee W. Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper. Eur Respir J 2004;23(6):932-946. (Pubitemid 38807371)
22. Crapo RO, Casaburi R, Coates AL, Enright PL, Hankinson JL, Irvin CG, et al for the American Thoracic Society. Guidelines for methacholine and exercise challenge testing-1999. Am J Respir Crit Care Med 2000;161(1):309-329.
23. Allen ND, Davis BE, Hurst TS, Cockcroft DW. Difference between dosimeter and tidal breathing methacholine challenge: contributions of dose and deep inspiration bronchoprotection. Chest 2005;128(6): 4018-4023. (Pubitemid 43062666)
24. Guss J, Mirza N. Methacholine challenge testing in the diagnosis of paradoxical vocal fold motion. Laryngoscope 2006;116(9):1558-1561. (Pubitemid 44368069)
25. Higgins BG, Britton JR, Chinn S, Jones TD, Vathenen AS, Burney PG, et al. Comparison of histamine and methacholine for use in bronchial challenge tests in community studies. Thorax 1988;43(8): 605-610. (Pubitemid 18207752)
26. Schmidt LE, Thorne PS, Watt JL, Schwartz DA. Is an abbreviated bronchial challenge with histamine valid? Chest 1992;101(1):141-145.
27. Porsbjerg C, Rasmussen L, Thomsen SF, Brannan JD, Anderson SD, Backer V. Response to mannitol in asymptomatic subjects with airway hyper-responsiveness to methacholine. Clin Exp Allergy 2007; 37(1):22-28. (Pubitemid 46011055)
28. Koskela HO, Hyvarinen L, Brannan JD, Chan HK, Anderson SD. Sensitivity and validity of three bronchial provocation tests to demonstrate the effect of inhaled corticosteroids in asthma. Chest 2003; 124(4):1341-1349. (Pubitemid 37290044)
29. Koskela HO, Hyvarinen L, Brannan JD, Chan HK, Anderson SD. Coughing during mannitol challenge is associated with asthma. Chest 2004;125:1985-1992. (Pubitemid 38788160)
30. Koskela HO, Hyvarinen L, Brannan JD, Chan HK, Anderson SD. Responsiveness to three bronchial provocation tests in patients with asthma. Chest 2003;124(6):2171-2177. (Pubitemid 38010586)
31. Brown LL, Martin BL, Morris MJ. Airway hyperresponsiveness by methacholine challenge testing following negative exercise challenge. J Asthma 2004;41(5):553-558. (Pubitemid 39202449)
32. Souza AC, Pereira CA. [Bronchial provocation tests using methacholine, cycle ergometer exercise and free running in children with intermittent asthma]. J Pediatr (Rio J) 2005;81(1):65-72. Article in Portuguese.
33. Gelber LE, Seltzer LH, Bouzoukis JK, Pollart SM, Chapman MD, Platts-Mills TA. Sensitization and exposure to indoor allergens as risk factors for asthma among patients presenting to hospital. Am Rev Respir Dis 1993;147(3):573-578. (Pubitemid 23072644)
34. Pollart SM, Chapman MD, Fiocco GP, Rose G, Platts-Mills TA. Epidemiology of acute asthma: IgE antibodies to common inhalant allergens as a risk factor for emergency room visits. J Allergy Clin Immunol 1989;83(5):875-882. (Pubitemid 19147178)
35. Greenberger PA. Allergic bronchopulmonary aspergillosis. J Allergy Clin Immunol 2002;110(5):685-692. (Pubitemid 35423169)
36. Douglass JA, O'Hehir RE. 1. Diagnosis, treatment and prevention of allergic disease: the basics. Med J Aust 2006;185(4):228-233. (Pubitemid 44322788)
37. Emanuel IA. In vitro testing for allergy diagnosis. Otolaryngol Clin North Am 2003;36(5):879-893.
38. Deykin A, Lazarus SC, Fahy JV, Wechsler ME, Boushey HA, Chinchilli VM, et al. Sputum eosinophil counts predict asthma control after discontinuation of inhaled corticosteroids. J Allergy Clin Immunol 2005;115(4):720-727. (Pubitemid 40460845)
39. Green RH, Brightling CE, McKenna S, Hargadon B, Parker D, Bradding P, et al. Asthma exacerbations and sputum eosinophil counts: a randomised controlled trial. Lancet 2002;360(9347):1715-1721. (Pubitemid 35447900)
40. Jatakanon A, Lim S, Kharitonov SA, Chung KF, Barnes PJ. Correlation between exhaled nitric oxide, sputum eosinophils, and methacholine responsiveness in patients with mild asthma. Thorax 1998; 53(2):91-95. (Pubitemid 28212132)
41. van den Toorn LM, Overbeek SE, de Jongste JC, Leman K, Hoogsteden HC, Prins JB. Airway inflammation is present during clinical remission of atopic asthma.AmJ Respir Crit Care Med 2001;164(11): 2107-2113.
42. Payne DN, Adcock IM, Wilson NM, Oates T, Scallan M, Bush A. Relationship between exhaled nitric oxide and mucosal eosinophilic inflammation in children with difficult asthma, after treatment with oral prednisolone. Am J Respir Crit Care Med 2001;164(8 Pt 1): 1376-1381. (Pubitemid 33124013)
43. Silkoff PE, Erzurum SC, Lundberg JO, George SC, Marczin N, Hunt JF, et al. ATS workshop proceedings: exhaled nitric oxide and nitric oxide oxidative metabolism in exhaled breath condensate. Proc Am Thorac Soc 2006;3(2):131-145.
44. Dupont LJ, Demedts MG, Verleden GM. Prospective evaluation of the validity of exhaled nitric oxide for the diagnosis of asthma. Chest 2003;123(3):751-756. (Pubitemid 36315489)
45. Fortuna AM, Feixas T, Gonzalez M, Casan P. Diagnostic utility of inflammatory biomarkers in asthma: Exhaled nitric oxide and induced sputum eosinophil count. Respir Med 2007;101(11):2416-2421. (Pubitemid 47495741)
46. Smith AD, Cowan JO, Filsell S, McLachlan C, Monti-Sheehan G, Jackson P, et al. Diagnosing asthma: comparisons between exhaled nitric oxide measurements and conventional tests. Am J Respir Crit Care Med 2004;169(4):473-478. (Pubitemid 38187119)
47. Silkoff PE, McClean P, Spino M, Erlich L, Slutsky AS, Zamel N. Dose-response relationship and reproducibility of the fall in exhaled nitric oxide after inhaled beclomethasone dipropionate therapy in asthma patients. Chest 2001;119(5):1322-1328. (Pubitemid 32686011)
48. Smith AD, Cowan JO, Brassett KP, Herbison GP, Taylor DR. Use of exhaled nitric oxide measurements to guide treatment in chronic asthma. N Engl J Med 2005;352(21):2163-2173. (Pubitemid 40727083)
49. American Association for Respiratory Care. AARC In the News. CPT Code for exhaled nitric oxide on the way. http://www.aarc.org/ headlines/cpt code noxide.cfm December 4, 2006. Accessed February 28, 2008.
50. Menzies D, Nair A, Lipworth BJ. Portable exhaled nitric oxide measurement: comparison with the "gold standard" technique. Chest 2007;131(2):410-414.
51. Aerocrine is proud to announce the introduction of NIOX Flex. Aerocrine, Solna, Sweden. http://www.nioxflex.com/us/index-start.html. Accessed February 29, 2008.
52. de Blic J, Scheinmann P. The use of imaging techniques for assessing severe childhood asthma. J Allergy Clin Immunol 2007;119(4): 808-810. (Pubitemid 46527822)
53. Park SW, Park JS, Lee YM, Lee JH, Jang AS, Kim DJ, et al. Differences in radiological/HRCT findings in eosinophilic bronchitis and asthma: implication for bronchial responsiveness. Thorax 2006; 61(1):41-47. (Pubitemid 43106976)
54. Global Initiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. Updated 2007. http://www.goldcopd. com. Accessed February 26, 2008.
55. Johannessen A, Omenaas ER, Bakke PS, Gulsvik A. Implications of reversibility testing on prevalence and risk factors for chronic obstructive pulmonary disease: a community study. Thorax 2005;60(10): 842-847. (Pubitemid 41475212)
56. Perez-Padilla R, Hallal PC, Vazquez-Garcia JC, Muino A, Maquez M, Lopez MV, et al. Impact of bronchodilator use on the prevalence of COPD in population-based samples. COPD 2007;4(2):113-120. (Pubitemid 47164863)
57. aO2, maximum work rate, and walking distance in patients with emphysema. Chest 2003;123(5):1394-1400.
58. Sin BA, Akkoca O, Saryal S, Oner F, Misirligil Z. Differences between asthma and COPD in the elderly. J Investig Allergol Clin Immunol 2006;16(1):44-50.
59. Fabbri LM, Romagnoli M, Corbetta L, Casoni G, Busljetic K, Turato G, et al. Differences in airway inflammation in patients with fixed airflow obstruction due to asthma or chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2003;167(3):418-424. (Pubitemid 36216426)
60. Maziak W, Loukides S, Culpitt S, Sullivan P, Kharitonov SA, Barnes PJ. Exhaled nitric oxide in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1998;157(3 Pt 1):998-1002. (Pubitemid 28150721)
61. Kuntz KM, Kitch BT, Fuhlbrigge AL, Paltiel AD, Weiss ST. A novel approach to defining the relationship between lung function and symptom status in asthma. J Clin Epidemiol 2002;55(6):11-18. (Pubitemid 34037033)
62. Stout JW, Visness CM, Enright P, Lamm C, Shapiro G, Gan VN, et al. Classification of asthma severity in children: the contribution of pulmonary function testing. Arch Pediatr Adolesc Med 2006;160(8): 844-850. (Pubitemid 44199245)
63. Sorkness CA. Traditional and new approaches to asthma monitoring. Respir Care 2008;53(5):593-599; discussion 599-601.